The effects of intravoxel contrast agent diffusion on the analysis of DCE-MRI data in realistic tissue domains
Ryan T. Woodall
Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas, USA
Center for Computational Oncology, Institute for Computational and Engineering Sciences, The University of Texas at Austin, Austin, Texas, USA
Search for more papers by this authorStephanie L. Barnes
Center for Computational Oncology, Institute for Computational and Engineering Sciences, The University of Texas at Austin, Austin, Texas, USA
Search for more papers by this authorDavid A. Hormuth II
Center for Computational Oncology, Institute for Computational and Engineering Sciences, The University of Texas at Austin, Austin, Texas, USA
Search for more papers by this authorAnna G. Sorace
Department of Internal Medicine, The University of Texas at Austin, Austin, Texas, USA
Search for more papers by this authorC. Chad Quarles
Barrow Neurological Institute, Phoenix, Arizona, USA
Search for more papers by this authorCorresponding Author
Thomas E. Yankeelov
Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas, USA
Department of Internal Medicine, The University of Texas at Austin, Austin, Texas, USA
Center for Computational Oncology, Institute for Computational and Engineering Sciences, The University of Texas at Austin, Austin, Texas, USA
Livestrong Cancer Institutes, The University of Texas at Austin, Austin, Texas, USA
Correspondence to: Thomas E. Yankeelov, PhD, Department of Biomedical Engineering, The University of Texas at Austin, 107 W. Dean Keeton Street, Stop C0800, Austin, TX 78712. E-mail: [email protected]Search for more papers by this authorRyan T. Woodall
Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas, USA
Center for Computational Oncology, Institute for Computational and Engineering Sciences, The University of Texas at Austin, Austin, Texas, USA
Search for more papers by this authorStephanie L. Barnes
Center for Computational Oncology, Institute for Computational and Engineering Sciences, The University of Texas at Austin, Austin, Texas, USA
Search for more papers by this authorDavid A. Hormuth II
Center for Computational Oncology, Institute for Computational and Engineering Sciences, The University of Texas at Austin, Austin, Texas, USA
Search for more papers by this authorAnna G. Sorace
Department of Internal Medicine, The University of Texas at Austin, Austin, Texas, USA
Search for more papers by this authorC. Chad Quarles
Barrow Neurological Institute, Phoenix, Arizona, USA
Search for more papers by this authorCorresponding Author
Thomas E. Yankeelov
Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas, USA
Department of Internal Medicine, The University of Texas at Austin, Austin, Texas, USA
Center for Computational Oncology, Institute for Computational and Engineering Sciences, The University of Texas at Austin, Austin, Texas, USA
Livestrong Cancer Institutes, The University of Texas at Austin, Austin, Texas, USA
Correspondence to: Thomas E. Yankeelov, PhD, Department of Biomedical Engineering, The University of Texas at Austin, 107 W. Dean Keeton Street, Stop C0800, Austin, TX 78712. E-mail: [email protected]Search for more papers by this authorAbstract
Purpose
Quantitative evaluation of dynamic contrast enhanced MRI (DCE-MRI) allows for estimating perfusion, vessel permeability, and tissue volume fractions by fitting signal intensity curves to pharmacokinetic models. These compart mental models assume rapid equilibration of contrast agent within each voxel. However, there is increasing evidence that this assumption is violated for small molecular weight gadolinium chelates. To evaluate the error introduced by this invalid assumption, we simulated DCE-MRI experiments with volume fractions computed from entire histological tumor cross-sections obtained from murine studies.
Methods
A 2D finite element model of a diffusion-compensated Tofts-Kety model was developed to simulate dynamic T1 signal intensity data. Digitized histology slices were segmented into vascular (vp), cellular and extravascular extracellular (ve) volume fractions. Within this domain, Ktrans (the volume transfer constant) was assigned values from 0 to 0.5 min−1. A representative signal enhancement curve was then calculated for each imaging voxel and the resulting simulated DCE-MRI data analyzed by the extended Tofts-Kety model.
Results
Results indicated parameterization errors of −19.1% ± 10.6% in Ktrans, −4.92% ± 3.86% in ve, and 79.5% ± 16.8% in vp for use of Gd-DTPA over 4 tumor domains.
Conclusion
These results indicate a need for revising the standard model of DCE-MRI to incorporate a correction for slow diffusion of contrast agent. Magn Reson Med 80:330–340, 2018. © 2017 International Society for Magnetic Resonance in Medicine.
Supporting Information
Additional Supporting Information may be found in the online version of this article.
Filename | Description |
---|---|
mrm26995-sup-0001-suppinfo01.pdf1.7 MB |
Fig. S1. (a) Simulated time-course for a necrotic voxel (see Fig. 2a), with contrast agent diffusivity, D = 1 × 10−4 mm2 s−1. Error for this simulation is −31.8% in Ktrans, −23.7% in ve, and 11.3% in vp. (b) The time-course for the same voxel, where D = 4 × 10−4 mm2 s−1. Error for this simulation is −15.5% in Ktrans, −0.2% in ve, and −26.8% in vp. Note that as D increases, the voxel equilibrates sooner and is associated with reduced error in parameter estimation. Higher diffusivity results in higher accuracy in Ktrans and ve. Underestimation of vp is because of the true value being < < 0.01 (vp = 0.003). Fig. S2. (a) depicts the simulated time-course for a well-perfused voxel (see Fig. 3a), with contrast agent diffusivity, D = 1 × 10−4 mm2 s−1. Error for this simulation is −30.3% in Ktrans, −5.7% in ve, and 49.9% in vp. (b) The time-course for the same voxel, where D = 4 × 10−4 mm2 s−1. Error for this simulation is −11.7% in Ktrans, −3.1% in ve, and 4.3% in vp. As with the necrotic voxel (Fig. 2 and Supporting Fig. S1), accuracy in Ktrans and ve is positively correlated with increasing D. Higher vp accuracy in the well-perfused voxel, compared to the poorly perfused voxel, is because of the increased vascularity in the domain (vp = 0.009). Fig. S3. Depiction of the parametric error as a function of domain size for parameters ve and vp. Error in Ktrans can be seen in Figure 6. (a) Corresponds to the domain shown in Figure 6a, while (b) corresponds to the domain shown in Figure 6b. (c) Corresponds to the domain shown in Figure 6c. Similar to Ktrans, ve and vp are most accurate with higher diffusivity. In general, as the domain is expanded around the vasculature, the accuracy of ve and vp decrease. Dashed lines on vp error plots indicate where true vp drops below 0.01. There is no dashed line in (c) because vp is always above 0.01. Spikes in the plot of ve error (b) are caused by the non-smooth changes in EES and true volume fractions as the domain increases in size. This non-smooth behavior is unavoidable using discretized steps in an irregular domain. The curves are less smooth for real tissue data, shown in (c). Fig. S4. (a) The error in Ktrans for mouse 2. Error in ve is shown in (b), and error in vp is shown in (c). Fig. S5. (a) The error in Ktrans for mouse 3. Error in ve is shown in (b), and error in vp is shown in (c). Fig. S6. (a) The error in Ktrans for mouse 4. Error in ve is shown in (b), and error in vp is shown in (c). Fig. S7. Comparison of in vivo DCE-MRI data to simulation results, obtained from the same specimen. (a) A fast spin echo image of the central slice of a BT474 tumor, with the tumor boxed in red. (b) Corresponding H&E histology from the same specimen. (c) Ktrans map resulting from fitting the measured signal time-course to in vivo DCE-MRI data. (d) Assigned Ktrans map resulting from the forward model with D = 2.6 × 10−4 mm2 s−1. Green ROIs correspond to a necrotic region near the center of the tumor, whereas blue ROIs correspond to a well-perfused region near the periphery of the tumor. (e,f) Measured and simulated signal intensity time-courses, respectively, associated with the green ROI from (c) and (d). The solid red lines in (e) and (f) present the fit of each signal intensity curve with the extended Tofts model. Similarly, (g) and (h) depict the measured and simulated signal intensity time-courses, respectively, associated with the blue ROI in (c) and (d). Again, the solid red lines in (g) and (h) depict the fit of each signal intensity curve with the extended Tofts model. Fitting to the curve in (e) resulted in Ktrans = 0.009 min−1, ve = 1105, and vp = 2.3E−14. The resulting parametric fit for the simulated curve in (f) was Ktrans = 0.019 min−1, ve = 185, and vp = 2.2E−14. The resulting fit for the curve in (g) was Ktrans = 0.0771 min−1, ve = 0.331, and vp = 0.039. Finally, the parametric fit for the simulated curve in (h) is Ktrans = 0.052 min−1, ve = 0.164, and vp = 0.024. The FEM model is able to recapitulate experimentally measured curve shapes in both poorly and well-perfused regions. When the region is poorly perfused (e.g., the green ROI), analysis with the extended Tofts model leads to non-physiological parameter estimations. When the region is well-perfused (e.g., the blue ROI), the extended Tofts model returns reasonable parameter values. |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1 Yankeelov T, Gore J. Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples. Curr Med Imaging Rev 2007; 3: 91–107.
- 2 Surov A, Meyer HJ, Gawlitza M, Höhn AK, Boehm A, Kahn T, Stumpp P. Correlations between DCE MRI and histopathological parameters in head and neck squamous cell carcinoma. Transl Oncol 2017; 10: 17–21.
- 3 Jia G, O'Dell C, Heverhagen J, Yang X, Liang J, Jacko R, Sammer S, Pellas T, Cole P, Knopp M. Colorectal liver metastases: contrast agent diffusion coefficient for quantification of contrast enhancement heterogeneity at MR imaging. Radiology 2008; 248: 901–909.
- 4 Daldrup H, Shames DM, Wendland M, Okuhata Y, Link TM, Rosenau W. Correlation of dynamic contrast enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR Am J Roentgenol 1998; 171: 941–949.
- 5 Haris M, Gupta RK, Singh A, Husain N, Husain M, Pandey CM, Srivastava C, Behari S, Singh Rathore RK. Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRI. Neuroradiology 2008; 50: 531–540.
- 6 Li X, Abramson RG, Arlinghaus LR, et al. Combined DCE-MRI and DW-MRI for predicting breast cancer pathological response after the first cycle of neoadjuvant chemotherapy. Invest Radiol 2015; 50: 195–204.
- 7 Li X, Kang H, Arlinghaus LR, Abramson RG, Chakravarthy B, Abramson VG, Farley J, Sanders M, Yankeelov TE. Analyzing spatial heterogeneity in DCE- and DW-MRI parametric maps to optimize prediction of pathologic response to neoadjuvant chemotherapy. Transl Oncol 2014; 7: 14–22.
- 8 Gaustad J, Pozdniakova V, Hompland T, Simonsen TG, Rofstad EK. Magnetic resonance imaging identifies early effects of sunitinib treatment in human melanoma xenografts. J Exp Clin Cancer Res 2013; 32: 93.
- 9 Whisenant JG, Sorace AG, Mcintyre JO, Kang H, Sanchez V, Loveless ME, Yankeelov TE. Evaluating treatment response using DW-MRI and DCE-MRI in trastuzumab responsive and resistant HER2-overexpressing human breast cancer xenografts. Transl Oncol 2014; 7: 768–779.
- 10 Abramson RG, Arlinghaus L, Dula A, et al. MRI biomarkers in oncology clinical trials. Magn Reson Imaging Clin N Am 2016; 24: 11–29.
- 11 Yankeelov TE, Arlinghaus LR, Li X, Gore JC. The role of magnetic resonance imaging biomarkers in clinical. Semin Oncol 2011; 38: 16–25.
- 12 Walker-Samuel S, Leach MO, Collins DJ. Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis. Phys Med Biol 2006; 51: 3593–3602.
- 13 Asselin M, O'Connor JPB, Boellaard R, Thacker NA, Jackson A. Quantifying heterogeneity in human tumours using MRI and PET. Eur J Cancer 2012; 48: 447–455.
- 14 Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991; 17: 357–367.
- 15 Pellerin M, Yankeelov TE, Lepage M. Incorporating contrast agent diffusion into the analysis of DCE-MRI data. Magn Reson Med 2007; 58: 1124–1134.
- 16 Pannetier NA, Debacker C, Mauconduit F, Christen T, Barbier EL. A simulation tool for dynamic contrast enhanced MRI. PLoS One 2013; 8: e57636.
- 17 Fluckiger JU, Loveless ME, Barnes SL, Lepage M, Yankeelov TE. A diffusion-compensated model for the analysis of DCE-MRI data: theory, simulations and experimental results. Phys Med Biol 2013; 58: 1983–1998.
- 18 Sourbron S. A tracer-kinetic field theory for medical imaging. IEEE Trans Med Imaging 2014; 33: 935–946.
- 19 Kety SS. The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 1951; 3: 1–41.
- 20 Koh TS, Hartono S, Thng CH, Lim TKH, Martarello L, Ng QS. In vivo measurement of gadolinium diffusivity by dynamic contrast-enhanced MRI: a preclinical study of human xenografts. Magn Reson Med 2013; 69: 269–276.
- 21
Gordon MJ,
Chu KC,
Margaritis A,
Martin AJ,
Ethier CR,
Rutt BK. Measurement of Gd-DTPA diffusion through PVA hydrogel using a novel magnetic resonance imaging method. Biotechnol Bioeng 1999; 65: 459–467.
10.1002/(SICI)1097-0290(19991120)65:4<459::AID-BIT10>3.0.CO;2-O CAS PubMed Web of Science® Google Scholar
- 22 Langø T, Mørland T, Brubakk AO. Diffusion coefficients and solubility coefficients for gases in biological fluids and tissues: a review. Undersea Hyperb Med 1996; 23: 247–272.
- 23 Saam BT, Yablonskiy DA, Kodibagkar VD, Leawoods JC, Gierada DS, Cooper JD, Lefrak SS, Conradi MS. MR imaging of diffusion of 3He gas in healthy and diseased lungs. Magn Reson Med 2000; 44: 174–179.
- 24 Johnson JA, Wilson TA. A model for capillary exchange. Am J Physiol 1966; 210: 1299–1303.
- 25 Larson B, Markham J, Raichle ME. Tracer-kinetic models for measuring cerebral blood flow using externally detected radiotracers. J Cereb Blood Flow Metab 1987; 7: 443–463.
- 26 Khalifa F, Soliman A, El-Baz A, El-Ghar MA, El-Diasty T, Gimel'farb G, Ouseph R, Dwyer AC. Models and methods for analyzing DCE-MRI: a review. Med Phys 2014; 41: 124301.
- 27 Barnes SL, Whisenant JG, Loveless ME, Yankeelov TE. Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretation. Pharmaceutics 2012; 4: 442–478.
- 28 Barnes SL, Quarles CC, Yankeelov TE. Modeling the effect of intra-voxel diffusion of contrast agent on the quantitative analysis of dynamic contrast enhanced magnetic resonance imaging. PLoS One 2014; 9: e108726.
- 29 Sorace AG, Quarles CC, Whisenant JG, Hanker AB, McIntyre JO, Sanchez VM, Yankeelov TE. Trastuzumab improves tumor perfusion and vascular delivery of cytotoxic therapy in a murine model of HER2 + breast cancer: preliminary results. Breast Cancer Res Treat 2016; 155: 273–284.
- 30
Tofts PS,
Brix G,
Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223–232.
10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S CAS PubMed Web of Science® Google Scholar
- 31 Lussanet QG De, Beets-tan RGH, Backes WH, van der Schaft DWJ, Engelshoven JMA, Mayo KH, Griffioen AW. Dynamic contrast-enhanced magnetic resonance imaging at 1.5 Tesla with gadopentetate dimeglumine to assess the angiostatic effects of anginex in mice. Eur J Cancer 2004; 40: 1262–1268.
- 32 Loveless ME, Halliday J, Liess C, Xu L, Dortch RD, Whisenant J, Waterton JC, Gore JC, Yankeelov TE. A quantitative comparison of the influence of individual versus population-derived vascular input functions on dynamic contrast enhanced-MRI in small animals. Magn Reson Med 2012; 67: 226–236.
- 33 Loveless ME, Lawson D, Collins M, Prasad Nadella MV, Reimer C, Huszar D, Halliday J, Waterton JC, Gore JC, Yankeelov TE. Comparisons of the efficacy of a Jak1/2 inhibitor (AZD1480) with a VEGF signaling inhibitor (Cediranib) and sham treatments in mouse tumors using DCE-MRI, DW-MRI, and histology. Neoplasia 2012; 14: 54–64.
- 34 Barnes SL, Sorace AG, Loveless ME, Whisenant JG, Yankeelov TE. Correlation of tumor characteristics derived from DCE-MRI and DW-MRI with histology in murine models of breast cancer. NMR Biomed 2015; 28: 1345–1356.
- 35 Shiroishi MS, Habibi M, Rajderkar D, et al. Perfusion and permeability MR imaging of gliomas. Technol Cancer Res Treat 2011; 10: 59–71.
- 36 Rundqvist H, Johnson RS. Tumour oxygenation: implications for breast cancer prognosis. J Intern Med 2013; 274: 105–112.
- 37 Stephens DJ, Allan VJ. Light microscopy techniques for live cell imaging. Science 2003; 300: 82–86.